Apellis Pharmaceuticals Aktie
18,27
EUR
-0,27
EUR
-1,45
%
21,69
USD
-0,33
USD
-1,50
%
Werbung
Apellis Pharmaceuticals Aktie Analyse
| 01.08.19 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 30.07.18 | Apellis Pharmaceuticals Buy | B. Riley FBR | |
| 24.05.18 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 12.04.18 | Apellis Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
| 08.02.18 | Apellis Pharmaceuticals Buy | B. Riley FBR, Inc. |
Werbung
Werbung